IMPACT OF COVID-19 ON PATIENTS WITH NEUTROPENIA FEBRUARY

Authors

  • Catharine Garcia Lopes Residente em Clínica Médica pelo Hospital Estadual de Urgências Governador Otávio Lage de Siqueira (HUGOL)
  • Guilherme Cristovam Pina Médico pela Universidade Evangélica de Goiás (UNIEVANGÉLICA)
  • Charbell Guthierry Almeida de Mendonça Médico pela Universidade Federal de Goiás (UFG)
  • Gabriella Batista Centurion de Santa Rosa Médica pela Universidade de Rio Verde (UniRV)
  • Gabriel Camargo Villas Boas Zambrin Médico pela Universidade Cidade de São Paulo (UNICID)
  • Bianca Dantas Vieira Médica pela Universidade Federal de Goiás (UFG)
  • Ana Karolina Gomes Médica pela Faculdade Morgana Potrich (FAMP)
  • Camila Freitas Barbosa Médica pelo Centro Universitário UniFG (UNIFG)
  • Jhessyka Burgatti Cardozo Médica pelo Centro Universitário de Várzea Grande (UNIVAG)
  • Vanessa Scandolara Loureiro Acadêmica em Medicina pelo Centro Universitário de Pinhais (UNIFAPI)
  • Luiz Antonio Minguetti Loureiro Médico Especialista em Medicina do Trabalho pela Associação Nacional de Medicina do Trabalho (ANAMT)
  • Geovanna Porto Inácio Médica Residente em Anestesiologia pelo Hospital Estadual de Anápolis Dr. Henrique Santillo (HEANA)

DOI:

https://doi.org/10.36557/2674-8169.2024v6n8p4661-4672

Keywords:

COVID-19, Febrile Neutropenia, Viral Infections.

Abstract

 

COVID-19 has posed significant challenges for patients with febrile neutropenia, a condition characterized by low neutrophil counts and fever, often resulting from chemotherapy treatments. This article aims to conduct a systematic review of the literature on the impact of COVID-19 on patients with febrile neutropenia, following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. The research was conducted in the PubMed, SciELO, and BVS databases, covering the last five years (2018-2023). The search strategy included terms such as "COVID-19," "febrile neutropenia," and "viral infections." The results indicate that patients with febrile neutropenia are at increased risk of severe complications and mortality when infected with SARS-CoV-2. The immunosuppression associated with neutropenia compromises the immune response, making these patients more susceptible to secondary infections and worsening of COVID-19. Additionally, the review highlights the need for specific management and treatment protocols for this vulnerable population, including the use of antiviral therapies, prophylactic antibiotics, and rigorous monitoring. It is concluded that COVID-19 exacerbates clinical challenges in patients with febrile neutropenia, requiring multidisciplinary approaches to minimize risks and improve clinical outcomes.

Downloads

Download data is not yet available.

References

Nunes MDR, Pacheco ST de A, Costa CIA, Silva JA da, Xavier W da S, Victória JZ. DIAGNOSTIC TESTS AND CLINICAL CHARACTERISTICS OF COVID-19 IN CHILDREN: AN INTEGRATIVE REVIEW. Texto contexto - enferm [Internet]. 2020;29:e20200156. Available from: https://doi.org/10.1590/1980-265X-TCE-2020-0156

Balduzzi A, Brivio E, Rovelli A, Rizzari C, Gasperini S, Melzi ML, et al. Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hematology center in Lombardia, Italy. Bone Marrow Transplant. 2020;55(10):1900-1901.

Bellesso M, Costa SF, Chamone DAF, Llacer PED. Triagem para o tratamento ambulatorial da neutropenia febril. Rev Bras Hematol Hemoter [Internet]. 2010;32(5):402–8. Available from: https://doi.org/10.1590/S1516-84842010000500014

Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2020;31(9):S299-S307.

Araujo SEA, Leal A, Centrone AFY, Teich VD, Malheiro DT, Cypriano AS, et al. Impact of COVID-19 pandemic on care of oncological patients: experience of a cancer center in a Latin American pandemic epicenter. einstein (São Paulo) [Internet]. 2021;19:eAO6282. Available from: https://doi.org/10.31744/einstein_journal/2021AO6282

Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, et al. A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international collaborative group. Oncologist. 2020;25(6):e936-e945.

Marcondes SS, Novaes ACZL, Cazeli AB, Lodi SF, Passamani JS, Belloti VL, et al. COVID-19: EXPERIÊNCIA DE ATENDIMENTO DOS PACIENTES ONCO-HEMATOLÓGICOS DO HOSPITAL SANTA CASA DE MISERICÓRDIA DE VITÓRIA. Hematology, Transfusion and Cell Therapy. 2020;42:527–528. https://doi.org/10.1016/j.htct.2020.10.890

Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337.

Başkol Elik D, Kaya Ş, Alkan S, Demirdal T, Sener A, Kaya S, et al. The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study. Scientific reports. 2024;14(1):5218. https://doi.org/10.1038/s41598-024-55886-w

Mehta V, Goel S, Kabarriti R, Cole D, Goldfinger M, Acuna-Villaorduna A, et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 2020;10(7):935-941.

Published

2024-08-27

How to Cite

Lopes , C. G., Pina , G. C., Mendonça, C. G. A. de, Rosa, G. B. C. de S., Zambrin, G. C. V. B., Vieira, B. D., Gomes, A. K., Barbosa , C. F., Cardozo, J. B., Loureiro, V. S., Loureiro, L. A. M., & Inácio, G. P. (2024). IMPACT OF COVID-19 ON PATIENTS WITH NEUTROPENIA FEBRUARY. Brazilian Journal of Implantology and Health Sciences, 6(8), 4661–4672. https://doi.org/10.36557/2674-8169.2024v6n8p4661-4672